Immune to Cancer: The CRI Blog
-
CICON16: Translating Science Into Survival
This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New…
-
Love Is On for $1 Million
Choose to love CRI in the second annual Revlon LOVE IS ON Million Dollar Challenge.
-
CRI Congratulates 2016 Lasker Award Winners
The Albert and Mary Lasker Foundation announced the 2016 recipients of the prestigious Lasker Awards, and CRI congratulates Charles…
-
Immunotherapy Patient Summit Agenda – Announced!
#CRISummit16 promises to be an educational and empowering day for cancer patients and their families.
-
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
Cancer Research Institute Featured in New York Times Cover Story on Cancer Immunotherapy
The pioneering work of CRI and its funded scientists are profiled in this special feature from the…
-
LabAnswer and Its Employees Raise More Than $50,000 for CRI
In January of 2016, CRI formed a new corporate philanthropy partnership with LabAnswer, the largest independent laboratory…
-
Announcing CRI’s Immunotherapy Patient Summit
This fall, CRI is bringing something very new to our patient community: our first-ever Immunotherapy Patient Summit,…
-
Ready. Raise. Rise. for CRI!
For the second year, CRI is participating in the Bristol-Myers Squibb Ready. Raise. Rise.™ Campaign to raise…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.